Rapamycin: Something Old, Something New, Sometimes Borrowed and Now Renewed
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference104 articles.
1. TOR Signaling in Growth and Metabolism
2. Growing roles for the mTOR pathway
3. Recent advances in the regulation of the TOR pathway by insulin and nutrients
4. Targeting the molecular target of rapamycin (mTOR)
5. The NF1 tumor suppressor critically regulates TSC2 and mTOR
Cited by 206 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploiting protein domain modularity to enable synthetic control of engineered cells;Current Opinion in Biomedical Engineering;2024-09
2. Infection risk in patients with autoimmune cytopenias and immune dysregulation treated with mycophenolate mofetil and sirolimus;Frontiers in Immunology;2024-05-30
3. Sirolimus in dermatology: Jack of many trades;Indian Journal of Dermatology, Venereology and Leprology;2024-04-29
4. Atypical Presentation and Evolution of Necrotizing Enterocolitis as a PIK3CA Pathological Variant;Cureus;2024-04-28
5. Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery;Advanced Drug Delivery Reviews;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3